SciELO - Scientific Electronic Library Online

 
vol.108 issue8Approval of chronic medication: discovery health hits new lows'No deals' for unlucky few strikers: HPCSA author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • On index processSimilars in Google

Share


SAMJ: South African Medical Journal

On-line version ISSN 2078-5135
Print version ISSN 0256-9574

SAMJ, S. Afr. med. j. vol.108 n.8 Pretoria Aug. 2018

 

IZINDABA

 

30 days in medicine

 

 

Penicillin allergies and superbug infections

Those with a penicillin allergy recorded in their medical records are at increased risk of developing the drug-resistant methicillin-resistant Staphylococcus aureus (MRSA) infection and the healthcare-associated infection Clostridium difficile, according to US research published in the BMJ.

Researchers at Massachusetts General Hospital, Boston, examined the relationship between penicillin allergy and development of MRSA and C. difficile using data from the Health Improvement Network, an electronic medical database of 11 million UK patients, and identified 64 141 adults with a documented penicillin allergy. None of the participants had any history of MRSA or C. difficile infection. They were followed up for an average of 6 years, during which use of antibiotics and cases of MRSA and C. difficile were recorded. After adjusting for known risk factors, researchers found that a penicillin allergy label was associated with a 69% increased risk of MRSA and a 26% increased risk of C. difficile. The results show that increased use of broad-spectrum antibiotics accounted for more than half (55%) of increased MRSA risk and more than one-third (35%) of the increased C. difficile risk among patients with a listed penicillin allergy.

Blumenthal KG, Lu N, Zhang Y, et al. Risk of methicillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: Population based matched cohort study. BMJ 2018;361:k2400. https://doi.org/10.1136/bmj.k2400.

 

Target breast cancer screening

A risk-stratified approach could improve the cost-effectiveness of breast cancer screening and reduce the 'cost' of overdiagnosis to women, according to a modelling study published in JAMA Oncology. According to the study, the age-based 'one-size-fits-all' breast screening approach does not take individual variation in risk into account.

A life-table model was created of a hypothetical cohort of 364 000 women in the UK, aged 50 years, with follow-up to age 85 years using findings of the Independent UK Panel on Breast Cancer Screening and risk distribution based on polygenic risk profile. The modelled interventions were no screening, age-based screening (based on the UK screening programme of a mammogram every 3 years from age 50 to 69 years) and risk-stratified screening (a proportion of women aged 50 years with a risk score greater than a threshold risk offered screening every 3 years to age 69).

Their finding was that a risk-stratified screening strategy could improve the benefit-to-harm ratio and the cost-effectiveness of the breast screening programme, with diminishing return with screening offered to women at lower risk.

Pashayan N, Morris S, Gilbert FJ. Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer. JAMA Oncol 2018 (epub 5 July 2018). https://doi.org/10.1001/jamaoncol.2018.1901

 

Full-fat dairy may be good for your heart

A new study from the Friedman School of Nutrition Science and Policy at Tufts University, Boston, USA, challenges the long-held belief that full-fat dairy products must be avoided. Published in the American Journal of Clinical Nutrition, the study suggests that some dairy fats may be beneficial for cardiovascular health.

The authors looked at the effect of dairy products on mortality risk and cardiovascular health in >2 900 US people, aged >65 years. They measured participants' blood plasma levels of three fatty acids contained by dairy products at the beginning of the study in 1992, and then 6 and 13 years later. During the 22-year follow-up period, 2 428 participants died and 833 deaths were due to heart disease. However, none of the three fatty acids examined correlated with the risk of total mortality. In fact, higher circulating levels of heptadeconic fatty acid were associated with a lower risk of death from heart disease. In addition, adults with higher levels of fatty acids overall were 42% less likely to die from stroke.

The authors suggest that these findings should lead to current dietary guidelines being amended and point out that dairy products are a rich source of nutrients such as calcium and potassium.

De Oliveira MC, Lemaitre RN, Song X, et al. Serial measures of circulating biomarkers of dairy fat and total and cause-specific mortality in older adults: The Cardiovascular Health Study. Am J Clin Nutr 2018 (epub 11 July 2018). https://doi.org/10.1093/ajcn/nqy117

B Farham

Editor

ugqirha@iafrica.com

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License